Pacific Biosciences of California, Inc. (PACB)
1.38
-0.14
(-9.21%)
USD |
NASDAQ |
Mar 06, 16:00
1.40
+0.02
(+1.45%)
After-Hours: 20:00
Pacific Biosciences of California SG&A Expense (TTM) : 141.49M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Beam Therapeutics, Inc. | 113.82M |
| Twist Bioscience Corp. | 260.54M |
| Boston Scientific Corp. | 6.888B |
| Intellia Therapeutics, Inc. | 119.80M |
| Enovis Corp. | 1.070B |